Merck misled regulators, legislators, and the medical community about the safety and efficacy of the Gardasil HPV vaccine. The vaccine manufacturer knowingly concealed the risks associated with Gardasil's ingredients, which include a potent neurotoxin and potentially hazardous DNA particles.
In seeking fast-track approval for Gardasil, Merck presented misleading data to the FDA suggesting that HPV infections and some abnormal cervical tissue inexorably result in cancer. Gardasil's approval was based on Merck's theory that HPV alone causes cervical cancer, and that the Gardasil vaccine could eliminate cervical cancer and other HPV-associated cancers. None of these contentions are true; Merck has never proven that Gardasil prevents cervical cancer or any type of cancer.
Contrary to Merck's assertions that Gardasil is a safe and effective tool for preventing cancer, studies have shown that systemic administration of Gardasil leads to increased rates of cervical cancer and other serious health issues, including severe side effects. Gardasil has more reported injuries than any other vaccine on the market.
